Infiltrated cardiac lipids impair myofibroblast-induced healing of the myocardial scar post-myocardial infarction

Atherosclerosis

Volumn 224, Issue 2, 2012, Pages 368-376

  Vilahur, Gemma ^a,b   Casani, Laura ^a   Juan Babot, Oriol ^a   Guerra, Jose M ^a   Badimon, Lina ^a,b,c  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cardiac function; Cardiac healing; Lipids; Myocardial infarction

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LIPID; PROTEIN KINASE B; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHOLESTEROL DIET; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIASTOLE; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART VENTRICLE ARRHYTHMIA; HYPERCHOLESTEROLEMIA; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; SWINE; SYSTOLE;

ANIMALS; APOLIPOPROTEINS B; APOPTOSIS; CHOLESTEROL ESTERS; CICATRIX; COLLAGEN; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOFIBROBLASTS; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SWINE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRIGLYCERIDES; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT; WOUND HEALING;

EID: 84866546468     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.07.003     Document Type: Article

References (35)

1. Osipov R.M., Bianchi C., Feng J., et al. Effect of hypercholesterolemia on myocardial necrosis and apoptosis in the setting of ischemia-reperfusion. Circulation 2009, 120:S22-S30.
2. Golino P., Maroko P.R., Carew T.E. The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion. Circulation 1987, 75:292-298.
3. Liu H.R., Tao L., Gao E., et al. Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation-a novel mechanism for the cardioprotective effects of PPAR agonists. Cardiovasc Res 2009, 81:344-352.
4. Lloyd-Jones D., Adams R.J., Brown T.M., et al. Heart disease and stroke statistics-2010 update: a report from the American heart association. Circulation 2011, 121:e46-e215.
5. Ballantyne C.M., Olsson A.G., Cook T.J., Mercuri M.F., Pedersen T.R., Kjekshus J. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation 2001, 104:3046-3051.
6. Cohn J.N., Ferrari R., Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol 2000, 35:569-582.
7. Su L., Siegel J.E., Fishbein M.C. Adipose tissue in myocardial infarction. Cardiovasc Pathol 2004, 13:98-102.
8. Goldfarb J.W., Arnold S., Roth M., Han J. T1-weighted magnetic resonance imaging shows fatty deposition after myocardial infarction. Magn Reson Med 2007, 57:828-834.
9. Ichikawa Y., Kitagawa K., Chino S., et al. Adipose tissue detected by multislice computed tomography in patients after myocardial infarction. JACC Cardiovasc Imag 2009, 2:548-555.
10. Maczewski M., Maczewska J., Duda M. Hypercholesterolaemia exacerbates ventricular remodelling after myocardial infarction in the rat: role of angiotensin II type 1 receptors. Br J Pharmacol 2008, 154:1640-1648.
11. Yaoita H., Yoshinari K., Maehara K., Sando M., Watanabe K., Maruyama Y. Different effects of a high-cholesterol diet on ischemic cardiac dysfunction and remodeling induced by coronary stenosis and coronary occlusion. J Am Coll Cardiol 2005, 45:2078-2087.
12. Vilahur G., Juan-Babot O., Pena E., Onate B., Casani L., Badimon L. Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. J Mol Cell Cardiol 2011, 50:522-533.
13. Vilahur G., Casani L., Pena E., Duran X., Juan-Babot O., Badimon L. Induction of RISK by HMG-CoA reductase inhibition affords cardioprotection after myocardial infarction. Atherosclerosis 2009, 206:95-101.
14. Newcomer S.C., Taylor J.C., Bowles D.K., Laughlin M.H. Endothelium-dependent and -independent relaxation in the forelimb and hindlimb vasculatures of swine. Comp Biochem Physiol Mol Integr Physiol 2007, 148:292-300.
15. Thomas W.P., Gaber C.E., Jacobs G.J., et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography committee of the specialty of cardiology, American college of veterinary internal medicine. J Vet Intern Med 1993, 7:247-252.
16. Cal R., Castellano J., Revuelta-Lopez E., et al. Low-density lipoprotein receptor-related protein 1 mediates hypoxia-induced very low density lipoprotein-cholesteryl ester uptake and accumulation in cardiomyocytes. Cardiovasc Res 2012, 94:469-479.
17. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
18. Cimmino G., Ibanez B., Vilahur G., et al. Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano). J Cell Mol Med 2009, 13:3226-3235.
19. Campos C., Guzman R., Lopez-Fernandez E., Casado A. Evaluation of the copper(II) reduction assay using bathocuproinedisulfonic acid disodium salt for the total antioxidant capacity assessment: the CUPRAC-BCS assay. Anal Biochem 2009, 392:37-44.
20. Goldfarb J.W., Roth M., Han J. Myocardial fat deposition after left ventricular myocardial infarction: assessment by using MR water-fat separation imaging. Radiology 2009, 253:65-73.
21. Kelly D.P., Hale D.E., Rutledge S.L., et al. Molecular basis of inherited medium-chain acyl-CoA dehydrogenase deficiency causing sudden child death. J Inherit Metab Dis 1992, 15:171-180.
22. Goonasekara C.L., Balse E., Hatem S., Steele D.F., Fedida D. Cholesterol and cardiac arrhythmias. Expet Rev Cardiovasc Ther 2011, 8:965-979.
23. Bilheimer D.W., Buja L.M., Parkey R.W., Bonte F.J., Willerson J.T. Fatty acid accumulation and abnormal lipid deposition in peripheral and border zones of experimental myocardial infarcts. J Nucl Med 1978, 19:276-283.
24. Reeves R.C., Evanochko W.T., Canby R.C., McMillin J.B., Pohost G.M. Demonstration of increased myocardial lipid with postischemic dysfunction (" myocardial stunning" ) by proton nuclear magnetic resonance spectroscopy. J Am Coll Cardiol 1989, 13:739-744.
25. Bujak M., Ren G., Kweon H.J., et al. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 2007, 116:2127-2138.
26. Castellano J., Aledo R., Sendra J., et al. Hypoxia stimulates low-density lipoprotein receptor-related protein 1 expression through HIF-1 alpha in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2011, 31:1411-1420.
27. Bacskai B.J., Xia M.Q., Strickland D.K., Rebeck G.W., Hyman B.T. The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 2000, 97:11551-11556.
28. Huang Y., Walker K.E., Hanley F., Narula J., Houser S.R., Tulenko T.N. Cardiac systolic and diastolic dysfunction after a cholesterol-rich diet. Circulation 2004, 109:97-102.
29. Hsu CP, Zhai P, Yamamoto T, et al. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation; 122:2170-82.
30. Zhou Y.T., Grayburn P., Karim A., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 2000, 97:1784-1789.
31. Baldi A., Abbate A., Bussani R., et al. Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 2002, 34:165-174.
32. Palojoki E., Saraste A., Eriksson A., et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 2001, 280:H2726-H2731.
33. Abbate A., Biondi-Zoccai G.G., Bussani R., et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol 2003, 41:753-760.
34. Dobrzycki S., Kozuch M., Kaminski K., et al. High cholesterol in patients with ECG signs of no-reflow after myocardial infarction. Rocz Akad Med Bialymst 2003, 48:118-122.
35. Li X.D., Cheng Y.T., Yang Y.J., et al. PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow. Microvasc Res 2012, 84:44-54.